Skip to main content
Grouped view 1739 records · Page 16/35

Prohibited Cosmetic Substances — Annex II

Annex II lists substances prohibited as intentionally added cosmetic ingredients. Article 17 separately addresses technically unavoidable unintended small quantities under good manufacturing practice and the Article 3 safety requirement. This page contains 1739 records.

How this annex works

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

Checked against

Annex II records

1739 total
Records in this list, 1739 in total
EntrySubstanceCASMax concentrationFlags
16863-methylpyrazoleCAS 1453-58-3 1453-58-3 CMR
1687N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide; pydiflumetofenCAS 1228284-64-7 1228284-64-7 CMR
1688N-{2-[[1,1'-bi(cyclopropyl)]-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide; sedaxaneCAS 874967-67-6 874967-67-6 CMR
16894-methylpentan-2-one; isobutyl methyl ketone (MIBK)CAS 108-10-1 108-10-1 CMR
169Caramiphen (INN) and its saltsCAS 77-22-5 77-22-5
1690Dimethomorph (ISO); (E,Z)-4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholineCAS 110488-70-5 110488-70-5 CMR
1691Imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acidCAS 114311-32-9 114311-32-9 CMR
1692Thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamineCAS 153719-23-4 153719-23-4 CMR
1693Triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanolCAS 138182-18-0 138182-18-0 CMR
1694Desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamateCAS 13684-56-5 13684-56-5 CMR
1695Ammonium bromideCAS 12124-97-9 12124-97-9
1696Dibutyltin bis(2-ethylhexanoate)CAS 2781-10-4 2781-10-4
1697Dibutyltin di(acetate)CAS 1067-33-0 1067-33-0
1698Tellurium dioxideCAS 7446-07-3 7446-07-3
1699Barium diboron tetraoxideCAS 13701-59-2 13701-59-2
17Isoprenaline (INN)CAS 7683-59-2 7683-59-2
170Diethyl 4-nitrophenyl phosphate (Paraoxon - ISO)CAS 311-45-5 311-45-5
17002,2-dimethylpropan-1-ol,tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-olCAS 36483-57-5/ 1522-92-5 36483-57-5/ 1522-92-5
17012,4,6-tri-tert-butylphenolCAS 732-26-3 732-26-3
17024,4’-sulphonyldiphenol; bisphenol SCAS 80-09-1 80-09-1
1703BenzophenoneCAS 119-61-9 119-61-9
1704Quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinoneCAS 2797-51-5 2797-51-5
1705Perfluoroheptanoic acid; tridecafluoroheptanoic acidCAS 375-85-9 375-85-9
1706methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalateCAS 283159-90-0 283159-90-0
17076-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts
17086-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acidCAS 2156592-54-8 2156592-54-8
17096-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid
171Metethoheptazine (INN) and its saltsCAS 509-84-2 509-84-2
1710Theophylline; 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dioneCAS 58-55-9 58-55-9
17111,3,5-triazine-2,4,6-triamine; melamineCAS 108-78-1 108-78-1
1712Fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamideCAS 607-285-6 607-285-6
1713N-(2-nitrophenyl)phosphoric triamideCAS 874819-71-3 874819-71-3
1714N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypramCAS 1255734-28-1 1255734-28-1
1715Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide [≥ 78 % syn isomers ≤ 15 % anti isomers relative content]; isopyrazamCAS 881685-58-1 881685-58-1
1716Margosa, ext. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents]CAS 84696-25-3 84696-25-3
1717CumeneCAS 98-82-8 98-82-8
17182-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate;CAS 15625-89-5 15625-89-5
1719Pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2-diylnitrilo)pentaacetateCAS 7216-95-7 7216-95-7
172Oxpheneridine (INN) and its saltsCAS 546-32-7 546-32-7
1720N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid); Pentetic Acid (INCI)CAS 67-43-6 67-43-6
1721Pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate; Pentasodium Pentetate (INCI)CAS 140-01-2 140-01-2
1722Acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidineCAS 135410-20-7/ 160430-64-8 135410-20-7/ 160430-64-8
1723Pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylideneCAS 40487-42-1 40487-42-1
1724Bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxideCAS 25057-89-0 25057-89-0
1725Styrene/Acrylates copolymer (nano) [INCI] Sodium Styrene/Acrylates copolymer (nano) [INCI]CAS 9010-92-8 9010-92-8
1726Copper (nano) [INCI] Colloidal Copper (nano) [INCI]CAS 7440-50-8 7440-50-8
1727Silver (nano) [1 nm < particle diameter ≤ 100 nm] Silver (massive) [particle diameter ≥ 1 mm]CAS 7440-22-4 7440-22-4
1728Gold (nano) [INCI], Colloidal Gold (nano) [INCI] [1] Gold Thioethylamino Hyaluronic Acid (nano) [INCI] [2] Acetyl heptapeptide-9 Colloidal gold (nano) [INCI] [3]CAS 7440-57-5 [1] / 1360157-34-1 [2]/ - [3] 7440-57-5 [1] / 1360157-34-1 [2]/ - [3]
1729Platinum (nano) [INCI], Colloidal Platinum (nano) [INCI] [1] Acetyl tetrapeptide-17 Colloidal Platinum (nano) [INCI] [2]CAS 7440-06-4 [1]/ - [2] 7440-06-4 [1]/ - [2]
173Ethoheptazine (INN) and its saltsCAS 77-15-6 77-15-6

How to use this grouped view

Annex II contains substances prohibited in cosmetic products. Use this grouped view when you want to scan 1739 prohibited-substance records quickly by name, identifier and linked entry page.

Open an individual record when you need the full legal wording, concentration logic, warnings or cross-links to related identifiers.